An Analysis of Blood Management in Patients Having Hip or Knee Arthroplasty

An Analysis of Blood Management in Patients Having Hip or Knee Arthroplasty in Siriraj Hospital: a Retrospective Study

The main objective of this study is to examine the transfusion rate and appropriateness in patients undergoing elective knee and hip replacement surgery at Siriraj Hospital

Study Overview

• Status: Completed
• Conditions: Transfusion-dependent Anemia

Detailed Description

The main objective of this study is to examine the transfusion rate and appropriateness in patients undergoing elective knee and hip replacement surgery at Siriraj Hospita by reviewing data from previous medical records (retrospective chart review).

• Study Type: Observational
• Enrollment (Actual): 275

Contacts and Locations

Study Locations

• Thailand
  • Bangkok, Thailand, 10700
    • Siriraj Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: ADULT; OLDER_ADULT; CHILD
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Patients Having elective Hip or Knee Arthroplasty in Siriraj Hospital

Description

Inclusion Criteria:

• Patients Having elective Hip or Knee Arthroplasty in Siriraj Hospital

Exclusion Criteria:

• none

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Perioperative transfusion rate	Transfusion rate in Patients Having Hip or Knee Arthroplasty in Siriraj Hospital	1 week

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Inappropriate transfusion rate	Perioperative inappropriate transfusion rate in Patients Having Hip or Knee Arthroplasty in Siriraj hospital	1 week

Collaborators and Investigators

• Sponsor: Siriraj Hospital
• Investigators: Principal Investigator: Mingkwan Wongyingsinn, MD, Faculty of Medicine Siriraj Hospital

Study record dates

Study Major Dates

• Study Start (ACTUAL): May 1, 2020
• Primary Completion (ACTUAL): December 30, 2020
• Study Completion (ACTUAL): September 20, 2021

Study Registration Dates

• First Submitted: March 9, 2020
• First Submitted That Met QC Criteria: March 9, 2020
• First Posted (ACTUAL): March 11, 2020

Study Record Updates

• Last Update Posted (ACTUAL): September 22, 2021
• Last Update Submitted That Met QC Criteria: September 20, 2021
• Last Verified: September 1, 2021

More Information

Terms related to this study

• Other Study ID Numbers: SIRB421_2

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No